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Hyperlipidemia is a rare cause of pancreatitis. It has been
believed that free fatty acids released from hydrolyzed serum
chylomicrons or triglycerides and chylomicrons induce hyper-
lipidemic pancreatitis by damaging acinar cells and capillaries.
Type I, IV or V hyperlipidemic (Fredrickson's classification)
pancreatitides have distinctive features of increased and
heightened serum chylomicron and triglyceride levels. In con-
trast, type IIb hyperlipidemia usually doesn't have increased
chylomicrons. It is a dominant inherited genetic disorder and
doesn't manifest the subjective symptom before combining
vascular complications such as coronary artery disease. Only
a few cases of type IIb hyperlipidemic pancreatitis have been
reported. We experienced a male patient with recurrent hyper-
lipidemic pancreatitis combined with type IIb hyperlipidemia.
We present the case report and a review of the literature of
hyperlipidemic pancreatitis, especially cases in Korea.
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INTRODUCTION
Hypertriglyceridemia is a rare cause of pan-
creatitis.
1 As known, serum pancreatic enzymes
may be normal or minimally elevated, even in the
presence of severe pancreatitis diagnosed by im-
aging studies. A serum triglyceride level of more
than 1,000 to 2,000 mg/dL in a patient with type
I, IV, V hyperlipidemia (Fredrickson's classifica-
tion) is an identifiable risk factor of acute pan-
creatitis.
2,3
The typical profile of hyperlipidemic pancrea-
titis is a preexisting lipid abnormality along with
secondary factor such as poorly controlled dia-
betes or alcohol abuse. Less commonly, a patient
with isolated hyperlipidemia (types V and I) with-
out precipitating factors also presents with pan-
creatitis. Familial combined hyperlipidemia has
also been described as a disorder in which multi-
ple lipoprotein phenotypes (types IIa, IIb, and IV)
occur in the same family.
4-6
Hyperlipidemic pancreatitis associated with
type I, IV or V hyperlipoproteinemia of Fre-
drickson's classification has been reported, but not
type IIb hyperlipoproteinemia with associated
pancreatitis. Recently, we experienced a patient
with hyperlipidemic pancreatitis due to type IIb
hyperlipoproteinemia. So, we present a patient
who had recurrent pancreatitis associated with
type IIb hyperlipoproteinemia and review the
literature in Korea.
CASE REPORT
A 28-year-old obese man presented at the Emer-
gency Room of our hospital complaining of
epigastric pain radiated to the back for one day.
He had been admitted to our hospital 3 times pre-
viously due to acute pancreatitis with hyperli-
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pidemia. He had type 2 diabetes mellitus and
active pulmonary tuberculosis. He was treated
with dietary restriction, daily NPH insulin injec-
tion, and lipid lowing medication such as fibrate
derivatives. His father was noted to have hyper-
tension, old cerebral infarction and type 2 diabetes
mellitus. His mother had hyperlipidemia (type IV)
and his elder brother had recurrent acute pancrea-
titis and diabetes mellitus. He didn't have xan-
thoma or xanthelasma. He had no alcohol drink-
ing history and no biliary calculus disease. His
height was 176 cm and weight was 87 kg, showing
marked obesity. On physical examination, his
abdomen was slightly distended with hypoactive
bowel sounds and he had direct tenderness on
epigastrium without rebound tenderness. On ad-
mission, laboratory data showed white blood cell
count of 15,210/mm
3. Blood chemistry tests re-
vealed fasting blood sugar level of 228 mg/dL,
lactate dehydrogenase level of 379 IU/L, and
aspartate aminotransferase level of 20 IU/L. The
serum amylase level of 160 mg/dL was slightly
higher than the normal range (25~125 mg/dL).
Serum lipase level was increased to 1596 U/L
(normal range of 13~60 U/L). Serum calcium level
and blood urea nitrogen level were within normal
limits. The lipid profiles such as total cholesterol,
triglyceride, high density cholesterol and low
density cholesterol were 272 mg/dL, 605 mg/dL,
28 mg/dL and 98 mg/dL, respectively. A diag-
nosis of type IIb hyperlipoproteinemia was made
based on serum lipoprotein electrophoresis [0% of
chylomicron (0-2.0), 62.9% of -lipoprotein (36.5- β
59.1), 22.5% of pre- -lipoprotein (3.8-33.8), and β
14.6% of -lipoprotein (20.4-46.4)]. Hemoglobin α
A1c level was 10.4% and fasting C-peptide and
postprandial C-peptide were 2.7 and 3.7 ng/mL,
respectively. Abdominal CT scan revealed dif-
fusely enlarged pancreas, peripancreatic fat infil-
tration and pelvic ascites, which were compatible
with acute pancreatitis grade C (Fig. 1). He was
treated with dietary restriction, hydration, NPH
insulin injection and lipid lowering agents. For the
purpose of distinguishing infective pancreatitis
from hyperlipidemic pancreatitis, we prescribed
antibiotics (2 g of meropenem per day) for two
days until abdominal CT information was ob-
tained. His abdominal pain was resolved within
a few days, and white blood cell count was nor-
malized. He was discharged after 8 days, with
complete recovery from acute pancreatitis.
DISCUSSION
Since Speck in 1865 reported the association
between hyperlipidemia and acute pancreatitis,
the relationship has been discussed in many
manuscripts.
1,3,7-10 Havel et al suggested a mecha-
nism that hypertriglyceridemia leads to pancrea-
titis.
11 The mechanism is thought to be that serum
chylomicrons or triglycerides are hydrolyzed by
lipase in the pancreatic capillaries to release free
fatty acids. Free fatty acids bind Ca
2+ and produce
pancreatic capillary damage or microthrombi,
leading to pancreatitis. Unbound free fatty acids
have a toxic effect on acinar cells or may injure
capillary vessels. Increased concentration of chylo-
microns in the pancreatic capillaries causes capil-
lary plugging and leads to ischemia and acidosis,
and in the acidic environment, free fatty acids
activate trypsinogen and initiate acute pancrea-
titis.
11
It has been believed that two signs of hyper-
lipidemic pancreatitis are high serum triglyceride
level above 1,000 mg/dL and the appearance of
chylomicron in the serum at the early stage of
pancreatitis.
3 Thus, lipoprotein electrophoresis of
Fig. 1. Abdominal CT scan shows diffusely enlargement,
peripancreatic fat infiltration (arrow) and pelvic ascites,
which were compatible with the diagnosis of acute
pancreatitis grade C.Byung Kook Kim, et al.
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hyperlipidemic pancreatitis is exhibited most com-
monly with type V hyperlipidemia, followed by
types I, and IV hyperlipidemia.
2,8 It is changed to
type I, IV or III hyperlipidemia in the recovery
stage of acute pancreatitis.
12
In our case, the patient showed type IIb hyper-
lipidemia. There were several mismatches com-
pared with typical hyperlipidemic pancreatitis in
our case. Firstly, the triglyceride level was only
605 mg/dL which was not compatible with the
belief that hyperlipidemic pancreatitis is asso-
ciated with a serum triglyceride level of more
than 1,000 mg/dL. According to Ohmoto et al,
there were two cases of pancreatitis associated
with a serum triglyceride level of lower than 1,000
mg/dL, among 33 cases of hyperlipidemic pan-
creatitis in Japan.
13 Cho et al. reported hyperli-
pidemic pancreatitis with a serum triglyceride
level of 416 mg/dL in Korea.
14 Secondly, there
was no chylomicron in type IIb hyperlipidemia, so
the role of chylomicron in hyperlipidemic pan-
creatitis was not explained. A few case reports
have shown that lipid profile was changed during
the recovery period of pancreatitis.
12,13,15-17 One
possible explanation is that our patient visited in
a fasting state one day after the onset of the
disease because he had already been known to
relieve the subjective symptom by fasting learned
through his previous experiences of pancreatitis.
This may have lowered the serum triglyceride and
chylomicron levels rapidly.
Our patient had suffered pancreatitis on 3 occa-
sions. Unfortunately, serum lipoprotein elec-
trophoresis was not been done, and therefore
Fredrickson's classification was not made. However,
on all 3 admissions, serum levels of triglyceride
were lower than 1000 mg/dL: 687 mg/dL, 927
mg/dL, and 451 mg/dL. During the follow up
period, his serum triglyceride levels were fre-
quently recorded at more than 1000 mg/dL with-
out pancreatitis symptoms. Serum hemoglobin
A1c level ranged from 7.7 to 11.0%, despite using
lipid lowering agents, such as gemfibrozils and
fibrate derivatives, and insulin therapy. Huang
and Raskin suggested that anti-hyperlipidemic
medications alone are usually not sufficient to
control hyperlipidemia in diabetic patients with
hypertriglyceridemia, and that antidiabetic medi-
cations must be used.
18 Poorly controlled diabetes
may induce hyperlipidemic pancreatitis in the
patient with type IIb hyperlipidemia. However,
the mechanism remains unclear, further research
is indicated.
In Korea, hyperlipidemic pancreatitis was first
reported by Lee et al. in 1986, after which six
cases, including our own, have been reported
(Table 1).
14-17,19,20 Most cases tended to have mild
to moderate symptoms and to be repeated epi-
sodes of pancreatitis, except two cases, one with
pregnancy and the other with acromegaly. Five
cases had diabetes mellitus. The most common
patient age was the third and fourth decade,
Table 1. Summary of Hyperlipidemic Acute Pancreatitis in Korea
Author Year Sex/Age
Past History
(frequency)
Fredrickson’s
classification
Triglyceride
(mg/dL)
Amylase
(mg/dL)
Treatment Outcome
Lee et al.
15 1986 F/30 AP(4) V IV 1278 1600 Conservative survival
Song et al.
16 1987 F/31 AP(2), DM V IV 1099 195 Conservative survival
Shin et al.
17 1993 M/45
AP(3), DM, HTN,
AMI, HTG
III IV 1222 413 Conservative survival
Jang et al.
19 1993 M/35 AP(3), DM V 2460 unchecked Conservative survival
Cho et al.
14 1995 F/25 IUP at 15 weeks none 416 469 Resection* survival
Lee et al.
20 2002 M/38 Acromegaly, DM none 1488 280 Conservative survival
Present case 2003 M/28 AP(3), DM IIb 605 160 Conservative survival
AP, acute pancreatitis; DM, diabetes mellitus; HTN, hypertension; AMI, acute myocardial infarction; HTG, hypertriglyceridemia; IUP,
Intrauterine pregnancy.
* Resection of pancreas and termination of pregnancy.Recurrent Acute Pancreatitis in a Patient with Type IIb Hyperlipoproteinemia
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ranging from 25 to 45 years (average: 33.1 years).
Only two patients had levels of serum triglyceride
lower than 1000 mg/dL, and one had more than
2000 mg/dL. Three cases were type V hyperli-
pidemia in the acute phase. As for treatment, one
case with pregnancy was treated surgically, with
termination of the pregnancy and resection of the
pancreas, while the other six were treated by
conservative treatment only.
There was a relatively lower incidence of
hyperlipidemic pancreatitis in Korea compared
with that in the West. The lower fat diet than the
typical Western diet may explain the lower in-
cidence of hyperlipidemic pancreatitis in Korea.
Nevertheless, the westernization of the Korean
dietary habit is increasing the incidence of hyper-
lipidemic pancreatitis. The low level of attention
toward this disease has possibly resulted in few
case reports and all the cases, except the pregnant
case and the acromegaly case, have recurred
frequently. So, accurate and rapid diagnosis, along
with early intensive therapy, are essential to treat
the recurrence of hyperlipidemic pancreatitis. To
prevent the recurrence of hyperlipidemic pan-
creatitis in diabetes patients, the necessary steps
include lower lipid diet education, encouraging
exercise, strict blood sugar control and medication
of lipid lowering agents.
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